Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 20,882 | 26,839 | 26,158 | 34,529 | 33,065 |
Operating Income | -20,882 | -26,839 | -26,158 | -34,529 | -33,065 |
Other Income | 2,406 | 2,052 | 1,311 | 1,661 | 1,576 |
Pre-tax Income | -18,476 | -24,787 | -24,847 | -32,868 | -31,489 |
Income Tax | N/A | N/A | -1,133 | 17 | 21 |
Net Income Continuous | -18,476 | -24,787 | -23,714 | -32,885 | -31,510 |
Net Income | $-18,476 | $-24,787 | $-23,714 | $-32,885 | $-31,510 |
EPS Basic Total Ops | -0.89 | -1.50 | -2.27 | -3.30 | -3.13 |
EPS Basic Continuous Ops | -0.89 | -1.50 | -2.34 | -3.26 | -3.13 |
EPS Diluted Total Ops | -0.89 | -1.50 | -2.27 | -3.30 | -3.13 |
EPS Diluted Continuous Ops | -0.89 | -1.50 | -2.34 | -3.26 | -3.13 |
EPS Diluted Before Non-Recurring Items | N/A | -1.50 | -2.30 | -3.30 | -3.10 |
EBITDA(a) | $-20,368 | $-26,175 | $-25,249 | $-33,180 | $-32,246 |